Correction to "Cetuximab-Polymersome-Mertansine Nanodrug for Potent and Targeted Therapy of EGFR-Positive Cancers"
Biomacromolecules
.
2022 Dec 12;23(12):5373-5374.
doi: 10.1021/acs.biomac.2c01278.
Epub 2022 Nov 9.
Authors
Shujing Yue
,
Yifan Zhang
,
Yaohua Wei
,
Rainer Haag
,
Huanli Sun
,
Zhiyuan Zhong
PMID:
36351000
DOI:
10.1021/acs.biomac.2c01278
No abstract available
Publication types
Published Erratum